Predictors of renal dysfunction at 1 year in heart transplant patients

Transplantation

Volumn 89, Issue 8, 2010, Pages 977-982

  Navarro Manchón, Josep ^a   Martínez Dolz, Luis ^a   Bonet, Luis Almenar ^a   Sánchez Lázaro, Ignacio ^a   Raso, Rafael Raso ^a   Grima, Esther Zorio ^a   Ramon Llin, Jaime Agüero ^a   Fuentes, Francisco Buendía ^a   Sánchez Gómez, Juan Miguel ^a   Sanz, Antonio Salvador ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cytomegalovirus; Heart transplantation; Mortality; Renal dysfunction

Indexed keywords

ACICLOVIR; AZATHIOPRINE; BASILIXIMAB; CREATININE; CYCLOSPORIN; DACLIZUMAB; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CREATININE; CYTOMEGALOVIRUS INFECTIONS; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951284437     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181cbe024     Document Type: Article

References (27)

1. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007; 26: 769.
2. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of nonrenal organ. N Engl J Med 2003; 349: 931.
3. Hamour I, Omar F, Lyster H, et al. Chronic kidney disease after heart transplantation. Nephrol Dial Transplant 2009; 24: 1655.
4. Arora S, Andreassen A, Simonsen S, et al. Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy. Transplantation 2007; 84: 149.
5. Miller LW, Pennington DG, McBride LR. Long-term effects of cyclo-sporine in cardiac transplantation. Transplant Proc 1990; 22: 15.
6. Goldstein DJ, Zuech N, Sehgal V, et al. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997; 63: 664.
7. Stratta P, Canavese C, Quaglia M, et al. Posttransplantation chronic renal damage in nonrenal transplant recipients. Kidney Int 2005; 68: 1453.
8. Ojo AO. Renal disease in recipients of nonrenal solid organ transplantation. Semin Nephrol 2007; 27: 498.
9. Levey A, Greene T, Kusek J, et al, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 2000; 11: 155A.
10. Delanaye P, Nellessen E, Grosch S, et al. Serum creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clin Transplant 2006; 20: 596.
11. Cantarovich M, Giannetti N, Cecere R. Correlation between serum creatinine, serum creatinine clearance, the calculated serum creatinine clearance and the glomerular filtration rateinheart transplant patients. J Heart Lung Transplant 2002; 21: 815.
12. Hendway A, Pouteil-Noble C, Villar E, et al. Chronic renal failure and end-stage renal disease are associated with a high rate of mortality after heart transplantation. Transplant Proc 2005; 37: 1352.
13. Cipullo R, Finger MA, Ponce F, et al. Renal failure as a determinant of mortality after cardiac transplantation. Transplant Proc 2004; 36: 989.
14. Al Aly Z, Abbas S, Moore E, et al. The natural history of renal function following orthotopic heart transplant. Clin Transplant 2005; 19: 683.
15. Russo MJ, Chen JM, Hong KN, et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation 2006; 114: 2280.
16. Sánchez-Lázaro IJ, Almenar Bonet L, Martínez-Dolz L, et al. Effect of hypertension, diabetes and smoking on development of renal dysfunction after heart transplantation. Transplant Proc 2008; 40: 3049.
17. Esposito C, Semeraro L, Belloti N, et al. Risk factors for chronic renal dysfunction in cardiac allograft recipients. Nephron 2000; 84: 21.
18. Rosenberg PB, Vriesendorp AD, Drazner MH, et al. Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. J Heart Lung Transplant 2005; 24: 1327.
19. Anselm A, Cantarovich M, Davies R, et al. Prolonged basiliximab use as an alternative to calcineurin inhibition to allow renal recovery late after heart transplantation. J Heart Lung Transplant 2008; 27: 1043.
20. Cheung CY, Liu YL, Wong KM, et al. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients. Nephrology (Carlton) 2008; 13: 251.
21. Morard I, Mentha G, Spahr L, et al. Long-term renal function after liver transplantation is related to CNI blood levels. Clin Transplant 2005; 20: 96.
22. Dische FE, Neuberger J, Keating J, et al. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporine A. Lab Invest 1988; 58: 395.
23. Rábago G, Manito N, Palomo J, et al. Improvement of chronic renal failure after introduction of mycophenolate mofetil and reduction of cyclosporine dose. J Heart Lung Transplant 2001; 20: 193.
24. Delgado J, Crespo-Leiro M, Almenar L, et al. Risk factors associated with moderate to severe renal failure in heart transplant patients. CAPRI Study. J Heart Lung Transplant [abstract] 2009; 28(suppl 1): S263.
25. Angermann C, Störk S, Costard-Jäckle A, et al. Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients\the IMPROVED multi-centre study. Eur Heart J 2004; 25: 1626.
26. Kobashigawa J, Miller L, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 1998; 66: 507.
27. Helanterä I, Koskinen P, Finne P, et al. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl Int 2006; 19: 893.